Yunnan Baiyao sold toothpaste on a secret no competitor was legally allowed to know

the problem

A premium toothpaste brand needed a claim rivals couldn't copy or contest

background

what everyone would do

Compete on the claims every toothpaste brand uses — whitening, natural ingredients, a celebrity dentist's endorsement. It fails structurally: any such claim can be reverse-engineered from the ingredient list and approximated by a rival within a single product cycle, so a premium position built on an ordinary formula claim has a built-in expiration date the moment a competitor decides to copy it.

what they saw

Yunnan Baiyao already possessed something no marketing claim could ever replicate: a formula classified as a permanent state secret, legally undisclosable even under regulatory or legal pressure. The move was recognizing that this constraint, an asset the company itself couldn't even fully reveal, could be carried sideways into an entirely new product category, where its untouchability became the whole premium position rather than staying confined to the wound-care line it originated in.

the move

Yunnan Baiyao's wound-powder formula is one of only two Chinese medicine formulas ever classified as a permanent state secret, undisclosable even to most regulators, since 1956. Rather than confine that mystique to wound care, the company launched a toothpaste in the mid-2000s built entirely around it: a medicinal, bleeding-gum treatment whose active ingredient no rival could name, reverse-engineer, or legally discuss, because the law itself sealed the formula.

why it works

Because the formula's secrecy is a legal classification, not a corporate choice, no competitor can ever obtain or verify what's in it, not through reverse-engineering, litigation, or regulatory disclosure — a form of protection no patent or ordinary trade secret can match, since those eventually expire or leak. Applying that same untouchable mystique to toothpaste gave the product a moat that had nothing to do with toothpaste R&D or marketing spend and everything to do with a decades-old regulatory status the company didn't need to build or defend anew. Rivals literally cannot compete on the same axis being claimed, forcing them onto weaker ground like price, while Yunnan Baiyao sustained roughly double Colgate's pricing on a claim that, unlike an ordinary ingredient claim, never degrades through imitation.

the payoff

Yunnan Baiyao toothpaste reached the number-two spot in China's toothpaste market by 2016 and number one by 2019, holding roughly a quarter of the market by value through the early 2020s while priced at about double Colgate. The health-products segment built around it generated on the order of ¥6.5 billion (about $900 million) in 2023–2024 revenue, helping carry the parent company from a fading state pharmaceutical maker to a market capitalization Forbes put around $13 billion.

where it breaks

The move only works if you actually hold a genuinely uncopyable, legally protected asset in the first place — most companies have nothing equivalent to a state-secret classification, and a manufactured substitute like a patent or ordinary trade secret offers far weaker protection since both can expire or leak. It also depends on finding an adjacent category where the asset's mystique genuinely transfers and does real product work, not an arbitrary stretch consumers see through — the extension needs a believable narrative bridge, which here was wound care plausibly extending into oral care through a shared logic of healing. And it requires the underlying legal protection to stay stable; if the classification were ever lifted, the entire moat would evaporate overnight, unlike a company-controlled secret the company itself decides whether to defend.

what came after

Yunnan Baiyao toothpaste became the top-selling toothpaste brand in China by value, and the brand-extension strategy is credited with much of the parent company's turnaround from a declining state enterprise into one of China's most valuable pharmaceutical groups — built on a regulatory classification, not a marketing budget, as the moat.

references

1. [1]Yunnan Baiyao: How One Company Brought Traditional Chinese Medicine To The Modern World And Made BillionsForbes, 2017forbes.com
2. [2]云南白药：云南白药牙膏实现市场份额25%，继续保持行业市场份额第一界面新闻, 2024jiemian.com
3. [3]云南白药Wikipedia, 2026zh.wikipedia.org

keep it

same kind of clever

• 1935 · BoeingAfter its own best test pilots crashed a plane by forgetting a single step, Boeing didn't train pilots harder — it wrote the steps down.
• 2020 · Burger King (Moldy Whopper campaign)Burger King proved its Whopper had no artificial preservatives by filming one decay into mold over 34 days and running the footage as the ad
• 2006 · Cedars-Sinai Medical CenterCedars-Sinai got doctors to wash their hands by photographing the bacteria growing on their own palms